This book investigates the pharmacological potential of plant-derived compounds in the development of novel anti-cancer therapies. Spiridon E. Kintzios, a recognized expert in plant biotechnology, synthesizes current research on secondary metabolites and their interaction with malignant cell lines. The text provides a rigorous framework for understanding how specific botanical extracts can be isolated, standardized, and applied within clinical oncology research.

Experts in the field of pharmacognosy recognize this work as a technical reference for researchers and graduate students. Readers frequently note the academic density of the prose and the specialized focus on biochemical pathways.